1. Home
  2. SLRC vs SGP Comparison

SLRC vs SGP Comparison

Compare SLRC & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SLR Investment Corp.

SLRC

SLR Investment Corp.

HOLD

Current Price

$13.34

Market Cap

803.0M

Sector

Finance

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$18.32

Market Cap

643.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLRC
SGP
Founded
2007
2019
Country
United States
United States
Employees
N/A
65
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
803.0M
643.9M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
SLRC
SGP
Price
$13.34
$18.32
Analyst Decision
Hold
Strong Buy
Analyst Count
7
5
Target Price
$15.14
$45.00
AVG Volume (30 Days)
558.8K
48.7K
Earning Date
05-05-2026
05-15-2026
Dividend Yield
10.49%
N/A
EPS Growth
N/A
N/A
EPS
0.31
N/A
Revenue
N/A
N/A
Revenue This Year
$1.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$42.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.83
$19.02
52 Week High
$17.20
$30.56

Technical Indicators

Market Signals
Indicator
SLRC
SGP
Relative Strength Index (RSI) 41.25 27.01
Support Level $12.83 N/A
Resistance Level $15.65 $26.29
Average True Range (ATR) 0.24 1.59
MACD 0.04 -0.43
Stochastic Oscillator 88.03 2.28

Price Performance

Historical Comparison
SLRC
SGP

About SLRC SLR Investment Corp.

SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: